Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.
Obesity Is One of the Strongest Risk Factor for Respiratory Failure and Death in COVID-19 Patients: A Retrospective Multicentric Cohort Study
32 Pages Posted: 12 May 2020
More...Abstract
Background: A significant spread of Coronavirus Disease 19 (COVID-19) has been observed in Western countries. The aim of the study was to analyze whether obesity (BMI ≥ 30 kg/m2) was a risk factor for respiratory failure and death.
Methods: Retrospective multicentric cohort study of 296 COVID-19 patients admitted to the hospital between February 28 and March 28, 2020. Demographic characteristics, laboratory findings and clinical scores were compared in obese and non-obese patients. Multivariable analysis was carried out to identify the risk factors for respiratory failure and mortality.
Findings: Of 296 patients, 70 (23·6%) had a BMI ≥ 30 kg/m2. Obese patients were significantly older (68±13·5 vs. 63±16·8, p=0·0052) and reported a higher rate of hypertension (77.9% vs. 40.2%, p<0.0001), chronic obstructive pulmonary disease (COPD) (24·3% vs. 9·7%, p=0·0017), type 2 diabetes (18·6% vs. 9·3%, p=0·033) and moderate/severe renal disease (12·9% vs. 2·7%, p=0·0007). Obese patients were more likely to require continuous positive airway pressure (20% vs. 7·8%, p=0·0052), non-invasive ventilation (20% vs. 7·5%, p=0·0061) and intensive care admission (40% vs. 15·9%, p<0·0001). At multivariable analysis, age and obesity were the only significant risk factors for the onset of respiratory failure (odds ratio [OR] 1·04, p<0·0001; OR 3·16, p=0·001) and mortality (OR 1·10, p<0.0001; OR 3·11, p=0·008).
Interpretation: Obesity is the strongest risk factor for respiratory failure and death among COVID-19 patients. Taking into account the high prevalence of obesity in the Western countries, prompt evaluation and aggressive treatment are advisable in obese patients.
Funding Statement: No funding was received for the study.
Declaration of Interests: The authors state that no conflicts of interest exist.
Ethics Approval Statement: The study was approved by the Ethical Committees of the participating centres.
Keywords: obesity; COVID-19; SARS-CoV-2; outcome; death; respiratory failure
Suggested Citation: Suggested Citation